Preliminary Investigation of the Area Under the L-Lactate Concentration-Time Curve (LACAREA) in Critically Ill Equine Neonates

被引:13
|
作者
Wilkins, P. A. [1 ]
Sheahan, B. J. [1 ]
Vander Werf, K. A. [1 ]
Castagnetti, C. [2 ]
Hardy, J. [3 ]
Schoster, A. [4 ]
Boston, R. C. [5 ]
机构
[1] Univ Illinois, Dept Vet Clin Med, Coll Vet Med, Urbana, IL 61082 USA
[2] Univ Bologna, Dept Vet Med Sci, Bologna, Italy
[3] Texas A&M Univ, Dept Large Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX USA
[4] Univ Zurich, Vetsuisse Fac, Zurich, Switzerland
[5] Univ Penn, New Bolton Ctr, Sch Vet Med, Dept Clin Studies, Kennett Sq, PA 19348 USA
关键词
Horse; Hyperlactatemia; Intensive care; Lactate clearance; Survival; ASSOCIATION; DIAGNOSIS;
D O I
10.1111/jvim.12559
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
BackgroundA variety of measures of l-lactate concentration ([LAC]) in the blood of critically ill neonatal foals have shown utility as prognostic indicators. These measures, evaluating either the severity of hyperlactatemia or the duration of exposure to hyperlactatemia, perform fairly well and have correctly classified 75-80% of foals examined in several studies. The area under the l-lactate concentration versus time curve (LAC(Area)) encompasses both severity and duration of hyperlactatemia and should improve correct classification of patient survival. Hypothesis/ObjectivesLAC(Area) is larger in nonsurviving critically ill neonatal foals. AnimalsForty-nine foals admitted for critical illness to 1 of 4 referral hospitals. MethodsWhole blood was obtained at admission and 6, 12, 18, and 24hours after admission for measurement of l-lactate using a handheld lactate meter. LAC(Area) was calculated for: admission-6, 6-12, 12-18, 18-24hours, and admission-24hours using the trapezoidal method and summing the 6-hours interval areas to determine total 24hours area. Differences between survivors and nonsurvivors were determined using robust regression and Kruskal-Wallis testing, P<.05. ResultsLAC(Area) was significantly larger in nonsurviving foals (n=9) than in surviving foals (n=40) at all time periods examined. Conclusions and Clinical ImportanceDifferences in LAC(Area) between surviving and nonsurviving critically ill neonatal foals are large and support further investigation of this method as an improved biomarker for survival in critically ill neonatal foals is indicated.
引用
收藏
页码:659 / 662
页数:4
相关论文
共 50 条
  • [1] Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients
    Ishigo, Tomoyuki
    Ibe, Yuta
    Fujii, Satoshi
    Kazuma, Satoshi
    Aigami, Tomohiro
    Kashiwagi, Yuri
    Takada, Ryo
    Takahashi, Satoshi
    Fukudo, Masahide
    Toda, Takaki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (08) : 769 - 777
  • [2] Association between Vancomycin Trough Concentration and Area under the Concentration-Time Curve in Neonates
    Frymoyer, Adam
    Hersh, Adam L.
    El-Komy, Mohammed H.
    Gaskari, Shabnam
    Su, Felice
    Drover, David R.
    Van Meurs, Krisa
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (11) : 6454 - 6461
  • [3] Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study
    Ishigo, Tomoyuki
    Matsumoto, Kazuaki
    Yoshida, Hiroaki
    Tanaka, Hiroaki
    Ibe, Yuta
    Fujii, Satoshi
    Fukudo, Masahide
    Fujihara, Hisato
    Yamaguchi, Fumihiro
    Ebihara, Fumiya
    Maruyama, Takumi
    Hamada, Yukihiro
    Samura, Masaru
    Nagumoi, Fumio
    Komatsu, Toshiaki
    Tomizawa, Atsushi
    Takuma, Akitoshi
    Chiba, Hiroaki
    Nishi, Yoshifumi
    Enoki, Yuki
    Taguchi, Kazuaki
    Suzuki, Ayako
    MICROBIOLOGY SPECTRUM, 2024, 12 (07): : e0373923
  • [4] Sequential L-lactate concentration in hospitalised equine neonates: A prospective multicentre study
    Borchers, A.
    Wilkins, P. A.
    Marsh, P. M.
    Axon, J. E.
    Read, J.
    Castagnetti, C.
    Pantaleon, L.
    Clark, C.
    Qura'n, L.
    Belgrave, R.
    Schwarzwald, C.
    Levy, M.
    Bedenice, D.
    Saulez, M. N.
    Boston, R. C.
    EQUINE VETERINARY JOURNAL, 2013, 45 : 2 - 7
  • [5] Flowchart for predicting achieving the target area under the concentration-time curve of vancomycin in critically ill Japanese patients: A multicenter retrospective study
    Ishigo, Tomoyuki
    Fujii, Satoshi
    Ibe, Yuta
    Aigami, Tomohiro
    Nakano, Keita
    Fukudo, Masahide
    Yoshida, Hiroaki
    Tanaka, Hiroaki
    Ebihara, Fumiya
    Maruyama, Takumi
    Hamada, Yukihiro
    Suzuki, Ayako
    Fujihara, Hisato
    Yamaguchi, Fumihiro
    Samura, Masaru
    Nagumo, Fumio
    Chiba, Hiroaki
    Takuma, Akitoshi
    Komatsu, Toshiaki
    Tomizawa, Atsushi
    Nishi, Yoshifumi
    Enoki, Yuki
    Taguchi, Kazuaki
    Matsumoto, Kazuaki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (04) : 329 - 336
  • [6] Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates
    Tseng, Sheng-Hsuan
    Lim, Chuan Poh
    Chen, Qi
    Tang, Cheng Cai
    Kong, Sing Teang
    Ho, Paul Chi-Lui
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [7] Appropriateness of basing vancomycin dosing on area under the concentration-time curve
    Dalton, Bruce R.
    Dersch-Mills, Deonne
    Langevin, Ashten
    Sabuda, Deana
    Rennert-May, Elissa
    Griener, Thomas
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (21) : 1718 - 1721
  • [8] INFLUENCE OF ROUTE OF ADMINISTRATION ON AREA UNDER PLASMA CONCENTRATION-TIME CURVE
    HARRIS, PA
    RIEGELMA.S
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (01) : 71 - &
  • [9] Limited Sampling Strategies to Predict the Area Under the Concentration-Time Curve for Rifampicin
    Medellin-Garibay, Susanna E.
    Correa-Lopez, Tania
    Romero-Mendez, Carmen
    Milan-Segovia, Rosa C.
    Romano-Moreno, Silvia
    THERAPEUTIC DRUG MONITORING, 2014, 36 (06) : 746 - 751
  • [10] CONSTANT BLOOD WITHDRAWAL METHOD FOR AREA UNDER PLASMA CONCENTRATION-TIME CURVE
    KOWARSKI, CR
    KOWARSKI, AA
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (06) : 875 - 876